Dr. Rick Adachi is a professor of medicine at McMaster University and a staff rheumatologist at St. Joseph's Healthcare Hamilton. He is also the inaugural holder of the Alliance for Better Bone Health Chair in Rheumatology. He is a graduate of McMaster University and has received his fellowship in Internal Medicine and in Rheumatology. Dr. Adachi is a member of the Scientific Advisory Council of Osteoporosis Canada and is a member of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF). Recently he was re-elected to the IOF Board of Directors. Dr. Adachi has conducted many clinical trials and has published extensively on a wide variety of therapies for the prevention and treatment of postmenopausal and corticosteroid-induced osteoporosis. He has participated in epidemiologic research assisting in the development of large databases looking at a wide variety of risk factors and therapies in osteoporosis. Dr. Adachi has participated in the development of guidelines for the treatment of primary and corticosteroid-induced osteoporosis in Canada. Dr. Adachi was awarded the First Annual Phillip Rosen Award in Rheumatology when he completed his training in Rheumatology. More recently Dr. Adachi was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he was awarded the Alliance for Better Bone Health Chair in Rheumatology at McMaster University and received the North American Menopause Society award for Innovation in Osteoporosis Research.
Dr. Ellen Amster is the Jason A. Hannah Chair in the History of Medicine at McMaster and Associate Professor, jointly appointed to the Department of Clinical Epidemiology and Biostatistics and the Department of History. She received her Ph.D. from the University of Pennsylvania in 2003, has been a simultaneous translator for an ORBIS eye surgery mission in Morocco, and created a global health field study program as the extension of her 2013 book, Medicine and the Saints: Science, Islam, and the Colonial Encounter in Morocco, 1877-1956 (University of Texas Press).
Dr. Sonia Anand is a professor of Medicine and Epidemiology at McMaster University, the Director of McMaster Population Genomics Program and a vascular medicine specialist. She recently received the Canada Research Chair in Ethnic Diversity and Cardiovascular Disease. She also holds both the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. Her present research focuses upon the environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease. Past education includes an undergraduate degree in Life Sciences from Queen’s University in 1989, a Doctor of Medicine from McMaster in 1992, Internal Medicine Training at McMaster and a Fellowship of the Royal College of Physicians and Surgeons of Canada in 1996. She further received her Masters in Clinical Epidemiology at McMaster in 1996 and Ph.D. in Health Research Methodology at McMaster in 2002. She completed a Heart and Stroke Foundation of Canada Research Fellowship in 1998, and in 2001 completed a Vascular Medicine Fellowship at Harvard University’s Brigham and Women's Hospital. In 1996, Dr. Anand received a Canadian Institutes of Health Research Clinician Scientist Award Phase 1 followed by the Phase 2 Award which she held from 2003-2008. She held the Eli Lily/May Cohen Chair in Women’s Health Research at McMaster from 2006-2013. Dr. Anand’s work is widely published amongst academic and peer-evaluated journals and she teaches clinical epidemiology courses in methodology and cardiovascular disease at McMaster University.
Dr. Dawn Bowdish completed her PhD training at the University of British Columbia with Dr. Bob Hancock where she determined that the perceived antibiotic activity of what were then called the “antimicrobial peptides” was in fact due to their immunomodulatory properties on host cells. Since then these peptides have been re-classified as “host-defence” peptides and they are currently in development for therapeutic use. She did her post-doctoral work with Prof. Siamon Gordon, a world renowned expert in macrophage biology. There she studied a class of macrophage phagocytic receptors called the scavenger receptors and found that the phagocytic process is linked in unexpected ways to pathogen sensing and the initiation of inflammation.
Dr. Bowdish is an assistant professor in the Department of Pathology & Molecular Medicine at McMaster University. She is affiliated with the McMaster Immunology Research Centre (MIRC) and the M. G. DeGroote Institute for Infectious Disease Research (IIDR). Her research focuses on how macrophages, which are the sentinel cells of the nasopharynx, distinguish between commensals and resident pathogens, especially with regard to understanding the importance of the phagocytic receptors making this important distinction. Since the nasopharynx is the gateway to respiratory infections such as pneumonia and influenza, her lab studies how immune control in this important geography breaks down with age and how systemic inflammation contributes to age-associated immune defects. Lastly, since the process of non-opsonic phagocytosis is integral to immune control of the nasopharynx, but the signalling behind this process is poorly understood, her lab aims to dissect the mechanisms of phagocytic signalling and how this contributes to signalling of other pattern recognition receptors such as the toll like receptors.Research in the Bowdish lab is funded by the CIHR, NSERC, NIH and OTS and is supported by the McMaster Immunology Research Centre and M. G. DeGroote Institute for Infectious Disease.
Dr. Jonathan Bramson is a professor in the Department of Pathology and Molecular Medicine and director of the McMaster Immunology Research Centre. Dr. Bramson has 18 years of experience in the field of cancer immunotherapy. The Bramson lab is developing strategies to direct T cells to attack tumors using biochemical and genetic methods. Dr. Bramson has also been involved in a number of translational studies evaluating novel cancer immunotherapies in early Phase clinical trials.
John Chenery is Communications Manager with the Ontario Lung Association. Previously, he was Director of Media and Communications for the International Barcode of Life Project at the University of Guelph. He also served as Director of Communications for the Green Party of Canada in Ottawa and for the Earth Council, an international environmental NGO based in Costa Rica. Mr. Chenery began his career as a journalist working for various newspapers in his native Australia, including a term in New York as North American correspondent for the Fairfax newspaper company. He also spent several years working on national newspapers and magazines in London, UK.
Dr. Mark Crowther received his M.D. from the University of Western Ontario in 1990. Between 1995 and 1999 Dr. Crowther undertook a focused Research Fellowship in Thromboembolism under the direction of Drs. Ginsberg, Weitz and Hirsh. Dr. Crowther joined the faculty at McMaster University in 1999 as an Assistant Professor in the Department of Medicine working at St. Joseph's Hospital. Currently, Dr. Crowther is a Professor in the Department of Medicine and Pathology and Molecular Medicine. He also is the Chief, Laboratory Medicine (St. Joseph's Healthcare and Hamilton Health Sciences Corporation), Director, Hamilton Regional Laboratory Medicine Program and the Vice President of Research (St. Joseph's Healthcare System). He is past chair of the Heart and Stroke Foundation of Canada Committee 1a (Clinical Trials). Dr. Crowther's clinical activities focus on the care of patients with thromboembolic disorders, the management of complications of treatments for thromboembolic disorders and other hematologic conditions. Dr. Crowther has presented more than 400 invited talks, published more than 290 peer-reviewed publications, spoken nationally and internationally and is the author of chapters in many bleeding hematologic texts. He is Senior Editor of a new text entitled Evidence Based Hematology and holds a Career Investigator award from the Heart and Stroke Foundation of Ontario and the Leo Pharma Chair in Thromboembolism Research at McMaster University.
Russell de Souza, RD, ScD is a CIHR post-doctoral research fellow in the Department of Clinical Epidemiology & Biostatistics, having completed his doctorate at the Harvard School of Public health. His current research interest is in systematic review methdoloogy applications in nutrition, with a major interest in diet and ischemic heart disease.
Dr. John Eikelboom, MBBS, MSc, FRCPC is associate professor in the Department of Medicine, McMaster University, and haematologist in the Thrombosis Service, Hamilton General Hospital, Ontario, Canada. He completed his training in internal medicine and haematology in Perth, Australia, in 1998 and subsequently undertook a Fellowship in Thrombosis Medicine and Clinical Research Methodology at McMaster University, Hamilton. He returned to McMaster in 2005 to take up a Tier II Canada Research Chair in Cardiovascular Medicine.
Dr. Julie Emili is the program director for the Public Health and Preventive Medicine program at McMaster University. Dr. Emili alsohas a family practice in the west end of Hamilton and is an Associate Medical Officer of Health (AMOH) for the City of Hamilton. As an AMOH, she is responsible for the vaccine program at Public Health Services. In addition, Dr. Emili acts as the liaison representative for the College of Family Physicians of Canada on the National Advisory Committee on Immunization.
Dr. Azim Gangji is an assistant professor in the Division of Nephrology, Department of Medicine at McMaster University.
Dr. Jack Gauldie, PhD, DSc, FRSC, is recognized for defining the molecular regulation by IL-6 of the acute phase inflammatory response, as well as the molecular regulation of Innate and Adaptive Mucosal Immunity. He is known for defining the role of cell and molecular factors such as TGFb in the regulation of chronic inflammatory and fibrotic diseases such as Pulmonary Fibrosis and Asthma. He has published over 360 scientific articles and numerous book chapters over his career. He was professor and chair of the Department of Pathology and Molecular Medicine for 15 years and is a Fellow of the Royal Society of Canada, and the Royal College of Physicians (Edinburgh). He also holds the title of Distinguished University Professor at McMaster. He is on the editorial board of a number of basic and clinical journals, including J Clin Invest, and is a regular reviewer of grants from Canadian, USA and UK granting agencies.
Sarah Glen is a video producer and community‐based participatory researcher. She has been facilitating participatory media projects for over 10 years with communities in both Ontario and B.C. She is specifically interested in how media can be used as a tool to help explore, amplify and support people facing challenges, while at the same time educating the broader community. She holds a master's degree in Communications and also co-‐instructs a community‐based participatory research to 3rd and 4th‐year students in the Bachelor of Health Sciences Honours Program at McMaster University. Sarah is currently working with the Hamilton Community Foundation, the City of Hamilton's Neighbourhood Development Strategy and other partners on an evidence‐based work plan to further develop Hamilton's Neighbourhood Leadership Institute. Her research interests include community‐based research; arts‐based and narrative inquiry; experiential education; critical pedagogy; ethical research responses and approaches with vulnerable populations; media studies; and youth engagement/empowerment in community‐based projects.
Dr. Gordon Guyatt is a distinguished professor of medicine at McMaster University who has been a leader in promoting the effective use of evidence to optimize clinical care. His work has been recognized with appointment as an Officer of the Order of Canada (2012) and Canadian Institute for Health Research Researcher of the Year (2013).
Dr. Steve Gyorffy is the director of specialty care medicine overseeing oncology and fibrotic diseases at Boehringer Ingelheim. He obtained his Ph.D in medical sciences at McMaster University in the molecular immunology and virology program with Dr. Jack Gauldie working in the field of cancer immunotherapy. This was followed by a postdoctoral fellowship at Harvard Medical School with Dr. Judah Folkman and Dr. Robert D’Amato exploring the mechanisms of tumor angiogenesis and blood vessel development. He has worked on the development of monoclonal antibodies and immune conjugates in addition to utilizing viral vectors and stem cells for modifying the tumor environment as well as understanding tissue growth/regeneration. In 2003, Dr. Gyorffy joined Boehringer Ingelheim Canada as a clinical scientist working on the clinical development of numerous targeted small molecules in oncology and immunology from Phase I to Phase III registration trials.
Dr. Todd Hoare is the Canada Research Chair in Engineered Smart Materials (Tier 2), a university scholar as well as an associate professor in the Department of Chemical Engineering at McMaster University. He received a B.Sc. (Eng.) in Engineering Chemistry from Queen’s University in 2001 and a Ph.D. in Chemical Engineering from McMaster in 2006. He returned to McMaster in 2008 to join the faculty after a two-year post-doctoral fellowship in Robert Langer’s laboratory at the Massachusetts Institute of Technology that was sponsored by NSERC (Natural Sciences and Engineering Research Council of Canada). Dr. Hoare’s work on "smart" environmentally-responsive hydrogels and nanoscale drug delivery vehicles has been profiled by Popular Science, Maclean’s, and BBC for its potential in solving clinical challenges through innovative materials design. He has won an NSERC Innovation Challenge award recognizing the novelty of his research. He has published over 80 papers that have been cited over 5000 times and has 11 filed or granted patents. He has received the 2016 Early Career Investigator Award from the Canadian Biomaterials Society, an Early Researcher Award and the 2009 John Charles Polanyi Prize in Chemistry from the Government of Ontario that recognized his accomplishments in his early career as a researcher. Dr. Hoare is the past-president of the Canadian Biomaterials Society, an associate editor of Chemical Engineering Journal and is a member of the Editorial Advisory Boards of Biomacromolecules and Colloid and Polymer Science.
Dr. Mark Inman completed his initial training in Exercise Physiology at the University of Waterloo (BSc '84, MSc '86). He then came to McMaster University to study the mechanics of breathing with Drs Kieran Killian and Moran Campbell (PhD '93). During this time he also completed a medical degree (MD '93). Rather than continuing with clinical training, Dr Inman chose to pursue a career in medical research, and began a 4 year post doctoral fellowship in the laboratory of Dr Paul O'Byrne. At this time, Dr Inman's research activities were divided between studies of the management of exercise induced bronchoconstriction and the role of the bone marrow in supporting allergen induced inflammation. Following his post-doctoral training, Dr Inman accepted a faculty position within the department of Medicine at McMaster. Since joining the faculty, Dr Inman has divided his time between research and educational activites. His research had focused on the mechanisms of airway hyperresponsiveness, a condition thought to play a major role in the frequent episodes of bronchoconstriction experienced by patients with asthma. To address this, Dr Inman has relied on models of allergen induced airway disease in mice, as well as sophisticated technology with which to assess lung function in small animals. Many of the models and research techniques were developed within Dr Inman's laboratory, either by his graduate students or his technicians, Russ Ellis and Jennifer Wattie. To date, Dr Inman has authored or co-authored over 100 peer reviewed manuscripts. Dr Inman's teaching interests have remained in the area of respiratory physiology; he currently teaches a graduate course in Respiratory Physiology that is also part of the required training for Respirology Residents at McMaster. Dr Inman also has a lifelong interest in research design and frequently offers sessions addressing common misunderstandings in various graduate student training forums.
Dr. Rosalyn Juergens has her clinical expertise in lung and esophageal cancer. Her areas of research expertise involve improving therapeutics and diagnostics in cancer. Dr. Juergens is an OICR Clinical Research Scholar. Dr. Juergens recently completed her Ph.D. in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Her research focus has been in developmental therapeutics with a concentration on Phase I and II clinical trials. She has been an investigator on several clinical trials assessing immune based therapy in lung cancer. Her imaging research focus is in the development of functional imaging technology. She has a particular interest in diagnostics and therapeutics in nuclear medicine including trials using FDG and FLT PET scans.
Dr. Martin Kolb is an associate professor of medicine and director of research for the Firestone Institute for Respiratory Health at St. Joseph's Healthcare. He obtained his MD from the University of Würzburg, Germany in 1991, where he also completed a PhD equivalent in Experimental Respirology in 2003. He trained with Dr. Jack Gauldie at McMaster University from 1999-2001 and they closely collaborate since then on basic and translational projects in pulmonary fibrosis. Dr. Kolb runs a specialty clinic for interstitial lung diseases and pulmonary fibrosis at St. Joseph's Healthcare and is involved as Principal Investigator and Steering Committee member in several multi-center trials for lung fibrosis. Dr. Kolb has published more than 80 scientific articles and is Deputy Editor for Respirology and on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine.
Dr. Brian Lichty has extensive expertise in oncolytic viruses and related immunotherapies. He has been a professor in the Department of Pathology and Molecular Medicine and the McMaster Immunology Research Centre (MIRC) at McMaster University since 2004. He is also the Chief Technology Officer and a co-founder of Turnstone Biologics. Dr. Lichty’s expertise includes influence research in the identification of strategies to leverage oncolytic viruses to harness the patient’s immune system in a sustainable manner, including vaccine design and engineering to directly engage the adaptive immune system tumour-specific and/or to enhance combinations with other immunotherapies. He is also co-director of the Robert E. Fitzhenry Vector Lab at McMaster where clinical grade viral vaccines are manufactured for human clinical trials. Dr. Brian Lichty received his PhD from the University of Toronto and holds a BSc from the University of Guelph.
Dr. Mark Loeb is an infectious disease physician and medical microbiologist. He is division director of infectious diseases and a professor with a joint appointment in pathology and molecular medicine and clinical epidemiology and biostatistics at McMaster University and holds the Michael G DeGroote Chair in Infectious Diseases.
Dr. Peter Margetts received both his MD and PhD degree from McMaster University. His clinical practice involves general nephrology, chronic kidney disease, and dialysis with a special interest in peritoneal dialysis. He teach in the undergraduate and post graduate medical school and he is presently the director of the MD/PhD program. Dr Margetts is a member of the Hamilton Centre for Kidney Research and McMaster Immunology Research Centre. He runs a basic research laboratory with interests in peritoneal dialysis, progressive renal disease and gene therapy. Dr Margetts collaborates with colleagues in human clinical and translational studies including evaluation of novel methods of volume assessment and markers of progressive kidney disease
Dr. Andrew Mente received his doctoral degree in Epidemiology from the University of Toronto. He completed post-doctoral training in cardiovascular epidemiology at McMaster University, and is currently an Assistant Professor in Clinical Epidemiology and Biostatistics at the Population Health Research Institute and Hamilton Health Sciences, McMaster University. He has received a Research Fellowship from the Heart and Stroke Foundation of Canada, and a Research Early Career Award from Hamilton Health Sciences.
Dr. Mente has studied the role of dietary components and patterns in the pathogenesis of cardiovascular diseases (CVD). His team conducted one of the largest ever systematic reviews of diet and coronary artery disease and helped to show that the causal evidence for most dietary exposures is modest or weak. He also has helped to identify an inexpensive diagnostic test (urinary potassium) for assessing diet quality in a clinical setting, and is particularly interested in the role of essential minerals (sodium, potassium, calcium, magnesium) in hypertension and CVD in populations around the world.
Dr. Mente is currently involved in the Population Urban and Rural Epidemiological (PURE) study, a large multi-national prospective cohort study investigating lifestyle behaviors, cardiovascular risk factors, and incidence of chronic diseases. His current focus is to find simple, practical and accurate ways to measure sodium and potassium intake in diverse populations, measure how much sodium people are consuming in these populations, identify an international reference range for sodium and potassium intake, and test whether the impact of sodium consumption on blood pressure and CVD varies across populations subgroups.
Dr. David Meyre is an associate professor of clinical epidemiology and biostatistics of McMaster University. He completed a PhD in quantitative plant genetics in France. Since 2001, he is working on the elucidation of the genetic bases of obesity and type 2 diabetes. His current research interests include the identification of novel susceptibility genes using high-throughput sequencing / genotyping approaches in populations representative of the worldwide ethnic background; a better understanding of the physiological and molecular mechanisms underlying the development of metabolic diseases; the interactions between genes and specific environmental exposures; and the usefulness of genetic information in clinical applications (prevention and care).
Dr. Matthew Miller completed his PhD in microbiology and immunology at the University of Western Ontario and trained as a postdoctoral fellow in the laboratory of Dr. Peter Palese at Mount Sinai Hospital in New York, NY, before establishing his own laboratory at McMaster University. His research focuses broadly on understanding how the body responds to viral infections. Recently, his group has focused extensively on influenza virus, and the development of a "universal" influenza virus vaccine.
After obtaining his medical degree (MBBS) from the University of Kerala in India in 1988, Dr. Paramsweran Nair trained in general and respiratory medicine at the University of Kerala Medical College Hospital in Trivandrum (with an MD for thesis on exercise-induced bronchoconstriction, Diploma in Tuberculosis, and National Board Certification in Respiratory Medicine (DNB), and Royal Sunderland and Royal Sussex County Hospitals in England (MRCP in General Medicine, 1996). He joined the faculty of Health Sciences of McMaster University in 2004 after training in Health Research Methodology, a clinical research fellowship and a PhD under the supervision of Professors Frederick Hargreave and Paul O’Byrne. He was elected a Member of the National Academy of Medical Sciences of India in 1993, Fellow of the College of Chest Physicians in 1999, Fellow of the Royal College of Physicians of London in 2003 and Fellow of the Royal College of Physicians of Canada in 2009 with certification in Internal Medicine and Respirology. In 2005, he was awarded the Ann Woolcock - American Thoracic Society prize for excellence in Asthma Research.
Dr. Nair's research focuses on developing and applying non-invasive measurements of airway inflammation in the treatment of asthma and COPD, particularly in patients with difficult-to-control and prednisone-dependent asthma. His laboratory characterizes the types of bronchitis in airway diseases using measurements in sputum, develops novel biomarkers in sputum, identifies mechanisms of bronchitis and explores novel targeted therapies of bronchitis.
Dr. Paul M. O’Byrne is the dean and vice-president of the Faculty of Health Sciences at McMaster University, and the dean of the Michael G. DeGroote School of Medicine. He is also a Distinguished University Professor of Medicine of McMaster, a world-renowned researcher and a practicing respirologist. He obtained his Medical Degree at University College, Dublin and his training in Internal Medicine and Respiratory Medicine at McMaster University. He undertook research training under the supervision of Dr. Freddy Hargreave at McMaster University and then Dr. Jay A. Nadel at the Cardiovascular Research Institute in San Francisco. His research interests are on the mechanisms and treatment of asthma with particular reference to the role of environmental allergens and the mechanisms by which these cause airway inflammation. He is also the executive director of the Firestone Institute for Respiratory Health at St. Joseph's Healthcare.
Dr. O'Byrne has published more than 380 peer reviewed papers, including papers in New England Journal of Medicine, Lancet, Nature Medicine, AJRCCM, JACI and Journal of Immunology. He has authored 90 book chapters, and edited 12 books. He has received the James H Graham Award of Merit, Royal College of Physicians and Surgeons of Canada, and has been the Distinguished Lecturer in Respiratory Sciences for Institute of Circulatory and Respiratory Health of the Canadian Institutes for Health Research. He was elected to the Royal Society of Canada in 2010, and was awarded the European Respiratory Society Congress Award and Medal in 2011. Dr. O'Byrne is the past-Chair of the Executive Committee of the Global Initiative for Asthma (GINA), is Associate Editor of Chest and International Archives of Allergy and Immunology, and is on the Editorial Board of the American Journal of Respirator and Critical Care Medicine and Thorax.
Dr. Alexandra Papaioannou is a professor of medicine and a geriatrician at St. Peter's Hospital, Hamilton Health Sciences. She also holds the Canadian Institute of Health and Research – Eli Lilly Chair in Osteoporosis and Fracture Prevention. She is the past Director of the Division of Geriatric Medicine, McMaster University with joint appointment in the Division of Rheumatology. Dr Papaioannou is an Associate Member in the Department of Clinical Epidemiology and Biostatistics and Medical Sciences. She is a member of the Scientific Advisors of Osteoporosis Canada and the International Osteoporosis Foundation. Dr Papaioannou was the lead author of the newly published Osteoporosis Canada Guidelines which were published in the October 2010 issue of the Canadian Medical Association Journal (CMAJ).
Dr Papaioannou has completed Masters of Science (MSc), Health Research Methods at McMaster University and was a prior Ontario Career Scientist. Dr. Papaioannou is past Chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and Chair of the Board. She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos).
Dr. Christopher Patterson is a Professor in the Division of Geriatric Medicine, Department of Medicine, Faculty of Health Sciences McMaster University, and former Chief of Geriatric Services, Hamilton Health Sciences. He has an active practice in Geriatric Medicine with a special interest in dementia and cognitive disorders. He is an investigator with the Canadian Longitudinal Study on Aging.
Dr. Jeffrey Pernica has research interests that are primarily focused on optimizing the diagnosis and treatment of respiratory and gastrointestinal infections in children living in both Canada and lower-resourced countries. He is currently the principal investigator of a multicentre randomized placebo-controlled study in Ontario seeking to define the proper length of antimicrobial therapy for mild community-acquired pneumonia and the principal investigator of a multicentre randomized factorial placebo-controlled study in Botswana whose goal is to improve treatment of acute paediatric diarrhoeal disease.
Dr. Ken Rosenthal is professor and division director of molecular medicine in the Department of Pathology & Molecular Medicine. He is also a member of the McMaster Immunology Research Centre and the Michael G. DeGroote Institute for Infectious Disease Research. He obtained his PhD at McMaster followed by postdoctoral research training with Prof. Rolf Zinkernagel (Nobel Laureate in Physiology or Medicine 1996) at Scripps Research Institute in California and the University of Zurich, Switzerland. Ken was a Scholar of the Medical Research Council (MRC) of Canada and Career Scientist Award from the Ontario HIV Treatment Network (OHTN). He has been involved in HIV/AIDS research since the disease was first identified. His research is focused on understanding pathogenesis and resistance to HIV-1 and herpes simplex virus (HSV) infections. In particular, his lab is pursuing understanding the role of innate and adaptive mucosal immune responses in HIV-1 and HSV infections. He is also involved in development of mucosal vaccines, adjuvants and microbicides against mucosally/sexually-transmitted viral infections. Recently, as part of a Bill & Melinda Gates collaborative study, his lab studied the role of innate immunity in HIV 'resistant' commercial sex workers in Kenya. Currently, as part of the Canadian HIV Vaccine Initiative (CHVI), he is heading up a large team collaborative investigation of cohorts of HIV-exposed uninfected breastfed infants in South Africa and Nigeria.
Dr. Zena Samaan is an assistant professor of psychiatry and behavioral neurosciences, an associate member of clinical epidemiology and biostatistics and a faculty member in the Population Genomics Program, McMaster University. Dr. Samaan is also a staff psychiatrist, member of the Royal College of Psychiatrists, UK and Certified Academic Psychiatrist by The College of Physicians and Surgeons of Ontario.
Dr. Samaan completed a Master’s in Science at the Department of Psychiatry, Trinity College Dublin, Ireland and further trained in psychiatric genetic epidemiology with Professors Peter McGuffin and Anne Farmer at the Institute of Psychiatry and Maudsley Hospital, London, UK where she obtained PhD in psychiatric genetics. Dr. Samaan is also a Staff Psychiatrist at St. Joseph’s Healthcare and Hamilton Health Sciences.
Clinical and Research Interests: Her clinical interests are centered on the interface between psychiatry and medicine specifically, depression comorbidity with obesity and cardiovascular disease. Her corresponding research interests are in psychiatric genetics, comorbidity of depression with cardiometabolic disorders, addiction and suicide risk factors.
Dr. Katrin Scheinemann was born in Germany and graduated from the University of Wuerzburg with a medical degree 1999 and completion of her doctoral thesis/ dissertation in 2002. After post-graduate training in general pediatrics in Switzerland, she started a fellowship in pediatric hematology and oncology in the Hospital for Sick Children in Toronto in 2006. The last fellowship year was exclusively pediatric neurooncology. After completion of her fellowship she was appointed to McMaster University in July 2008 as assistant professor for pediatric hematology and oncology. She is the chair of the multidisciplinary pediatric neurooncology program there as well as the pediatric palliative care initiative. Dr. Scheinemann's main research interests are in neurooncology, especially in the field of low grade gliomas and quality of life as well as palliative care in pediatric oncology.
Dr. Jonathan Schertzer is an assistant professor of biochemistry and biomedical sciences and of pediatrics at McMaster University. He did his BSc in kinesiology at the University of Waterlo, followed by a MSc with Professor Howard Green working on exercise and muscle biochemistry at the University of Waterloo. He then went on to do a PhD in Australia, working at The University of Melbourne, with Professor Gordon Lynch. He was awarded the Chancellor's prize (for top annual PhD) for his work investigating gene therapy, tissue regeneration and muscular dystrophy. He further completed a Postdoctoral fellowship at Sick Kids in Toronto, Canada with Professor Amira Klip in cellular biology working on aspects of glucose transport related to diabetes. He came to McMaster as the DeGroote Academic Fellow in The Department of Medicine in 2010 and started his laboratory in 2012. Jonathan is currently focussed on linking inflammation and bacterial sensors to obesity and metabolic diseases. He is also interested in the inflammatory basis of myopathies. He has currently 51 peer-reviewed publications and is on the Editorial board for The American Journal of Physiology. He enjoys chasing his kids, hockey and unfortunately is a Leafs fan.
Margaret Secord has been a facilitator/instructor in the Bachelor of Health Sciences (Honours) Program since its inception in 2000. She has facilitated multiple courses, including: Inquiry, Group Dynamics, Community Development, Peer Tutoring and Health, Attitude & Behaviour. Her educational background includes a Bachelor of Education and a Masters in Applied School Psychology and experience in clinical and educational settings. During her time in BHSc, she has been involved in numerous curriculum development initiatives, as well as mentoring of faculty and students. One highlight of her contributions to BHSc is her collaboration with Sarah Glen in developing an Engaging the City course, which introduces students to community-based participatory research in the city of Hamilton. Also, in 2012, Margaret was a co-creator of the new Child Health Specialization in BHSc. Margaret's involvement and contributions to BHSc continue to grow and develop.
Dr. Karun Singh has a research focus studying neural stem cells and their role in brain development disorders. His program has a specific emphasis on understanding the biology of psychiatric disease genetic risk factors, as these disorders have a strong genetic basis. Dr. Singh is using new mouse and human neural stem cell models to conduct his studies. This includes the use of recent breakthroughs in the stem cell field to generate patient-derived brain cells.
Dr. Sheila Singh is a pediatric neurosurgeon at McMaster Children's Hospital, and scientist appointed to the Stem Cell and Cancer Research Institute at McMaster University. She grew up in Dundas, Ontario and obtained her BSc in neurobiology and molecular genetics from McGill University, Montreal. She then pursued her MD at McMaster University, and was subsequently accepted into the neurosurgery residency program at University of Toronto. During her residency, she entered the Surgeon Scientist Program at University of Toronto and undertook a PhD in the molecular biology of brain tumours at the Arthur and Sonia Labatt Brain Tumour Research Centre, the Hospital for Sick Children, Toronto. Her PhD thesis described the novel identification of a population of cancer stem cells that exclusively drive the formation of brain tumours, and was published in the journals Cancer Research and Nature. Following the completion of her PhD, she undertook a fellowship in pediatric neurosurgery at The Hospital for Sick Children, Toronto. She now practices as a surgeon scientist at McMaster Children's Hospital, with a clinical interest in brain tumours that complements the ongoing characterization of brain tumour stem cell populations in her new laboratory. She holds a Canada Research Chair in Human Cancer Stem Cell Biology. She lives with her husband and two young sons in Dundas..
Dr. Peter Szatmari has worked in the field of autism spectrum disorders (ASD) for over 30 years. He is Professor and Head, Division of Child and Adolescent Psychiatry in the Department of Psychiatry and Behavioural Neurosciences at McMaster University, where he holds the Chedoke Health Chair in Child Psychiatry. He is Director of the Offord Centre of Child Studies, a research institute supported by McMaster University and McMaster Children's Hospital and is a founding member of the Canadian Autism Intervention Research Network (CAIRN) a national network of parents, clinicians, policy makers and scientists dedicated to supporting a research agenda in early intervention in autism.
Dr. Fiona Smaill is Professor and Chair of the Department of Pathology and Molecular Medicine in the Faculty of Health Sciences, McMaster University and a Medical Microbiologist for the Hamilton Regional Laboratory Medicine Program. She is a consultant in Infectious Diseases and Infection Control, and co-director of the HIV clinic at Hamilton Health Sciences. Dr. Smaill has her MD from the University of Otago in New Zealand, completed her residencies in Internal Medicine, Infectious Diseases, and Medical Microbiology at McMaster University and has her MSc in Epidemiology. Her research involves clinical trials in HIV, new vaccines for tuberculosis, and systematic reviews on infections in pregnancy.
Chantal Van Raay is manager of administration and communications in the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster University. She obtained a bachelor of arts with a minor in anthropology from the University of Windsor and a diploma in print journalism from Sheridan College. She started her journalism career at the Guelph Mercury and Metroland Publishing before entering the world of corporate communications as a communications specialist at the University of Western Ontario. She has worked at McMaster for more than 10 years, first in the Office of Public Relations as a web editor and communications specialist and in the IIDR working to promote the institute, its members and cutting-edge research facilities.
Dr. Ted Witek is a health care advisor and scholar based in Toronto and Lisbon. He currently serves as senior vice-president, corporate partnerships, and chief scientific officer at Innoviva in San Francisco (formerly Theravance, Inc). He is also appointed a senior fellow at the Institute of Health Policy, Management, and Evaluation (IHPME) of the University of Toronto and adjunct professor at the Dalla Lana School of Public Health and the Faculty of Pharmacy. Prior to joining Theravance, Dr. Witek, served as President and Chief Executive Officer, Boehringer Ingelheim in Canada from 2008-2014, and in Portugal from 2004-2008. Dr. Witek holds a doctor of public health degree from Columbia University, a master of public health from Yale University, and a master of business administration from Henley Management College in London.